Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. 2009

P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci, 14, 43100 Parma, Italy.

OBJECTIVE Innate immunity appears to be silent in acutely hepatitis B virus (HBV)-infected chimpanzees, as shown by microarray analysis of intrahepatic gene expression. Whether this observation also applies to HBV pathogenesis in man remains undefined. The aim of this study was thus to characterise natural killer (NK) and CD56(+) natural T (NT) cell responses early after human HBV infection and their relationship to the induction of adaptive immunity. METHODS Two HBV-seronegative blood donors who became hepatitis B surface antigen (HBsAg) and HBV DNA positive but had persistently normal alanine aminotransferase (ALT) were followed from a very early stage of HBV infection. The phenotype (CD69 and NKG2D) and function (cytotoxicity and interferon gamma (IFN gamma) production) of NK and NT cells were analysed. CD4- and CD8-mediated responses were studied in parallel with overlapping peptides covering the entire HBV sequence by ex vivo intracellular cytokine staining (ICS) for IFN gamma, interleukin 2 (IL2), IL4 and IL10, and by ex vivo Elispot for IFN gamma. Healthy subjects, and patients with chronic and acute HBV infection were studied for comparison. RESULTS An early induction of both innate and adaptive responses was observed. NK and NT cells showed faster kinetics than HBV-specific T cells with an earlier peak of activity, while CD4(+) and CD8(+) cell responses were mounted with a similar profile, with higher frequencies of IFN gamma-producing CD8(+) cells at the peak of the response. CONCLUSIONS The innate immune system is able to sense HBV infection, as shown by the early development of NK and NT cell responses, which probably contribute to contain the HBV infection and to allow timely induction of adaptive responses.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
January 2010, Digestive diseases (Basel, Switzerland),
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
February 2014, Virology journal,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
May 2012, FEMS microbiology reviews,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
December 2012, Gut,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
May 2013, Postgraduate medical journal,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
March 2022, World journal of gastroenterology,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
July 2010, Viruses,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
May 2019, Microbiology spectrum,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
June 2016, World journal of hepatology,
P Fisicaro, and C Valdatta, and C Boni, and M Massari, and C Mori, and A Zerbini, and A Orlandini, and L Sacchelli, and G Missale, and C Ferrari
January 2013, Seminars in immunopathology,
Copied contents to your clipboard!